Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer's diseases.

Journal of Neurochemistry
Elisa N Simões-PiresRafael Linden

Abstract

Systemic multimorbidity is highly prevalent in the elderly and, remarkably, coexisting neuropathological markers of Alzheimer's (AD) and cerebrovascular (CVD) diseases are found at autopsy in most brains of patients clinically diagnosed as AD. Little is known on neurodegeneration peculiar to comorbidities, especially at early stages when pathogenesis may propagate at subclinical levels. We developed a novel in vitro model of comorbid CVD/AD in organotypic hippocampal cultures, by combining oxygen-glucose deprivation (OGD) and exposure to amyloid-Aβ oligomers (AβOs), both applied at levels subtoxic to neurons when used in isolation. We focused on synaptic proteins and the roles of glutamate receptors, which have been implicated in many basic and clinical approaches to either CVD or AD. Subtoxic insults by OGD and AβOs synergized to reduce levels of synaptophysin (SYP) and PSD-95 without cell death, while effects of antagonists of either metabotropic or ionotropic glutamate receptors were distinct from reports in models of isolated CVD or AD. In particular, modulation of glutamate receptors differentially impacted SYP and PSD-95, and antagonists of a single receptor subtype had distinct effects when either isolated or combined. O...Continue Reading

References

Apr 1, 1991·Journal of Neuroscience Methods·L StoppiniD Muller
Jan 1, 1995·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·A AlzheimerF R Murtagh
Apr 1, 1997·The Gerontologist·D A Snowdon
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P LambertW L Klein
Jun 27, 2000·Neurobiology of Aging·R N Kalaria
Oct 12, 2002·Brain Research·Guang-Ping XuMiguel A Pérez-Pinzón
Sep 12, 2003·Trends in Pharmacological Sciences·Domenico E Pellegrini-Giampietro
Jan 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pascale N LacorWilliam L Klein
May 16, 2007·Annals of Neurology·Julie A SchneiderDavid A Bennett
Dec 8, 2007·Neurobiology of Aging·Liang LiWeidong Le
Aug 8, 2008·Neurochemical Research·Rudimar Luiz FrozzaChristianne Gazzana Salbego
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Colleen M Niswender, P Jeffrey Conn
Feb 4, 2010·Journal of Neuroscience Research·Takuya WatanabeMichihiro Fujiwara
Nov 4, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisDebby W Tsuang
Mar 16, 2011·Ageing Research Reviews·Alessandra MarengoniLaura Fratiglioni
Jul 23, 2011·Stroke; a Journal of Cerebral Circulation·Philip B GorelickUNKNOWN American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Counci
Sep 15, 2011·Neurobiology of Learning and Memory·Sergio T Ferreira, William L Klein
Jan 12, 2012·The Journal of Biological Chemistry·Adriano SebollelaSergio T Ferreira
May 30, 2012·The European Journal of Neuroscience·Elisabetta GeraceDomenico E Pellegrini-Giampietro
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Lennart Mucke, Dennis J Selkoe
Jul 17, 2012·Experimental Gerontology·Andrius Baskys, Jin-xiang Cheng
Oct 31, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Zhan LiuZhiqiang Su
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sadegh NabaviRoberto Malinow
Jun 7, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cláudia P FigueiredoSergio T Ferreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.